Quoin Pharmaceuticals Ltd DRC (QNRX) — Cash Flow-to-Debt Ratio
Latest as of March 2026:
-0.70x
Quoin Pharmaceuticals Ltd DRC (QNRX) has a Cash Flow-to-Debt Ratio of -0.70x as of March 2026, meaning its operating cash flow of $-4.87 Million could theoretically repay -1% of its total liabilities ($6.92 Million) in one year. See Quoin Pharmaceuticals Ltd DRC free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
-0.70x
Operating CF / Total Liabilities
Operating Cash Flow
$-4.87 Million
USD
Total Liabilities
$6.92 Million
USD
Data as of
Mar 2026
Most recent filing
Quoin Pharmaceuticals Ltd DRC Cash Flow-to-Debt Ratio (2015–2025)
Historical debt coverage capacity for Quoin Pharmaceuticals Ltd DRC across 11 annual periods. For the full cash flow conversion analysis, see Quoin Pharmaceuticals Ltd DRC (QNRX) cash flow conversion.
Annual Cash Flow-to-Debt Ratio for Quoin Pharmaceuticals Ltd DRC (2015–2025)
Year-by-year debt coverage analysis for Quoin Pharmaceuticals Ltd DRC.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.86x | $-13.54 Million | $7.27 Million | ▼ -54.2% |
| 2024 | -1.21x | $-7.86 Million | $6.50 Million | ▲ +0.1% |
| 2023 | -1.21x | $-7.86 Million | $6.51 Million | ▼ -0.5% |
| 2022 | -1.20x | $-8.48 Million | $7.05 Million | ▼ -82.9% |
| 2021 | -0.66x | $-5.72 Million | $8.70 Million | ▼ -292.2% |
| 2020 | -0.17x | $-1.34 Million | $7.99 Million | ▲ +94.5% |
| 2019 | -3.04x | $-5.71 Million | $1.88 Million | ▲ +16.9% |
| 2018 | -3.66x | $-6.57 Million | $1.80 Million | ▼ -143.8% |
| 2017 | -1.50x | $-4.98 Million | $3.32 Million | ▲ +43.9% |
| 2016 | -2.67x | $-3.77 Million | $1.41 Million | ▲ +1.0% |
| 2015 | -2.70x | $-1.98 Million | $735.02K | — |
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.